NASDAQ:CYTK

Cytokinetics Stock Insider Trading

etoro logo Buy CYTK
*Your capital is at risk
$77.13
-3.29 (-4.09%)
At Close: Jul 31, 2026

Cytokinetics Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be negative at -87.49. In total, the insiders bought 350.57K and sold 220.17K CYTK shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power

(Last 100 transactions)
-87.49
Buy 350.57K shares
Sell 220.17K shares
76% Buy Activity
Moderate Negative Correlation
Sell Signal High Confidence
Mar 17, 2026

Analysis Breakdown:

  • Strongly supported by a very low Insider Power Score of -87.49.
  • Partially supported by a negative historical correlation.
  • Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date Type Person Role Amount
Jul 30, 2026
Buy
Non-Qualified Stock Option (Right to Buy)
M-Exempt
Callos Andrew
EVP, Chief Commercial Officer
Officer 14 000
Value: $325.6K
Jul 30, 2026
Buy
Common Stock
M-Exempt
Callos Andrew
EVP, Chief Commercial Officer
Officer 14 000
Value: $325.6K
Jul 30, 2026
Sell
Common Stock
S-Sale
Callos Andrew
EVP, Chief Commercial Officer
Officer 14 000
Value: $1.12M
Jul 27, 2026
Buy
Common Stock
M-Exempt
Blum Robert I
President & CEO
CEO / President 7 500
Value: $79.5K
Jul 27, 2026
Sell
Common Stock
S-Sale
Blum Robert I
President & CEO
CEO / President 7 500
Value: $606.5K
Jul 27, 2026
Buy
Non-Qualified Stock Option (Right to Buy)
M-Exempt
Blum Robert I
President & CEO
CEO / President 7 500
Value: $79.5K
Jul 21, 2026
Sell
Common Stock
S-Sale
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $282.1K
Jul 21, 2026
Buy
Common Stock
M-Exempt
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $27.3K
Jul 21, 2026
Buy
Non-Qualified Stock Option (Right to Buy)
M-Exempt
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $27.3K
Jul 15, 2026
Buy
Common Stock
A-Award
Daly James M
Director
Director 151
Value: $12.5K
Jul 15, 2026
Buy
Common Stock
A-Award
Harrington Robert Arthur
Director
Director 151
Value: $12.5K
Jul 15, 2026
Buy
Common Stock
A-Award
Kaye Edward M. Md
Director
Director 151
Value: $12.5K
Jul 15, 2026
Buy
Common Stock
A-Award
Wierenga Wendell
Director
Director 75
Value: $6K
Jul 15, 2026
Buy
Common Stock
A-Award
Wysenski Nancy
Director
Director 75
Value: $6K
Jul 15, 2026
Buy
Common Stock
A-Award
Henderson John T
Director
Director 272
Value: $22.5K
Jul 13, 2026
Buy
Common Stock
M-Exempt
Blum Robert I
President & CEO
CEO / President 7 490
Value: $79.4K
Jul 13, 2026
Sell
Common Stock
S-Sale
Blum Robert I
President & CEO
CEO / President 7 490
Value: $614.3K
Jul 13, 2026
Buy
Non-Qualified Stock Option (Right to Buy)
M-Exempt
Blum Robert I
President & CEO
CEO / President 7 490
Value: $79.4K
Jul 07, 2026
Sell
Common Stock
S-Sale
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $303.2K
Jul 07, 2026
Buy
Common Stock
M-Exempt
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $27.3K
Jul 07, 2026
Buy
Non-Qualified Stock Option (Right to Buy)
M-Exempt
Malik Fady Ibraham
EVP Research & Development
Officer 3 500
Value: $27.3K
Jul 01, 2026
Sell
Common Stock
S-Sale
Lee Sung
EVP, Chief Financial Officer
C-Suite Officer 1 112
Value: $97.6K
Jul 01, 2026
Sell
Common Stock
S-Sale
Blum Robert I
President & CEO
CEO / President 7 500
Value: $636.9K
Jul 01, 2026
Sell
Common Stock
S-Sale
Callos Andrew
EVP, Chief Commercial Officer
Officer 15 000
Value: $1.29M
Jul 01, 2026
Buy
Common Stock
M-Exempt
Callos Andrew
EVP, Chief Commercial Officer
Officer 15 000
Value: $348.9K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

Click to get the best stock tips daily for free!
ABOUT CYTOKINETICS
Cytokinetics
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in pati...
GOLDEN STAR
Ticker Change Signal Date
FOX
$50.81
2.22% Jul 27
UNFI
$49.05
3.63% Jul 27
BIIB
$202.19
0.376% Jul 24
TSCO
$30.32
1.48% Jul 23
S
SW
$43.71
5.17% Jul 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE